Published online Mar 28, 2014. doi: 10.5412/wjsp.v4.i1.1
Revised: January 14, 2014
Accepted: January 17, 2014
Published online: March 28, 2014
Heart transplantation is commonplace, the supply is limited. Many exciting changes in the field of mechanical circulatory support have occurred in the past few years, including the axial flow pump. Left ventricular assist device (LVAD) therapy is ever evolving. As the use of LVAD therapy increases it is important to understand the indications, surgical considerations and outcomes.
Core tip: Left ventricular assist devices provide a durable, long-term alternative to heart transplant for those with end-stage heart failure. In an era of limited transplant donor supply, axial flow pumps are a viable alternative.